Related Experiment Video
Updated: Jan 19, 2026
08:56
A Method for Measuring RNA N6-methyladenosine Modifications in Cells and Tissues
Published on: December 5, 2016
11.3K
DART-seq: an antibody-free method for global m6A detection.
Kate D Meyer1,2
1Department of Biochemistry, Duke University School of Medicine, Durham, NC, USA. kate.meyer@duke.edu.
Nature Methods
|September 25, 2019
Summary
A new antibody-free method, DART-seq, detects N⁶-methyladenosine (m⁶A) RNA modifications using minimal RNA input. This technique offers a sensitive and efficient way to map m⁶A sites and study their dynamics in cells.
Area of Science:
- Molecular Biology
- Epigenetics
- RNA Biology
Background:
- N⁶-methyladenosine (m⁶A) is a crucial RNA modification impacting mRNA fate.
- Current m⁶A mapping methods rely on antibodies, facing limitations like high RNA needs and cross-reactivity.
Purpose of the Study:
- To develop an antibody-free method for sensitive and accurate m⁶A site detection.
- To overcome the limitations of existing m⁶A mapping technologies.
Main Methods:
- DART-seq utilizes a fusion protein of cytidine deaminase APOBEC1 and m⁶A-binding YTH domain.
- APOBEC1-YTH induces C-to-U deamination adjacent to m⁶A sites.
- Detected m⁶A sites via standard RNA-sequencing and long-read sequencing.
Main Results:
- DART-seq identifies thousands of m⁶A sites using as little as 10 ng of total RNA.
- The method allows for tracking m⁶A accumulation over time.
- Long-read DART-seq provides insights into m⁶A distribution within individual transcripts.
Conclusions:
- DART-seq is a powerful, antibody-free tool for m⁶A profiling.
- It offers high sensitivity and efficiency for m⁶A site detection and dynamic analysis.
- Enables deeper understanding of m⁶A modification's role in RNA biology.
